|
IGF2R expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.04740000017989E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.281300E-03 |
| Normal-vs-Stage2 |
1.57541999999955E-05 |
| Normal-vs-Stage3 |
3.61070000010066E-07 |
| Normal-vs-Stage4 |
4.73940000000894E-06 |
| Stage1-vs-Stage2 |
2.385700E-02 |
| Stage1-vs-Stage3 |
3.980100E-03 |
| Stage1-vs-Stage4 |
3.483800E-03 |
| Stage2-vs-Stage3 |
9.612400E-01 |
| Stage2-vs-Stage4 |
7.352200E-01 |
| Stage3-vs-Stage4 |
6.640600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.40129999960071E-07 |
| Normal-vs-AfricanAmerican |
5.245900E-04 |
| Normal-vs-Asian |
3.006000E-01 |
| Caucasian-vs-AfricanAmerican |
6.616600E-01 |
| Caucasian-vs-Asian |
5.931000E-01 |
| AfricanAmerican-vs-Asian |
4.736400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.48720000337744E-08 |
| Normal-vs-Female |
8.415900E-04 |
| Male-vs-Female |
7.123600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.049600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.810500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.85400000018987E-07 |
| Normal-vs-Age(81-100Yrs) |
2.2884999999917E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.345000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.264000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.910200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.369770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.094630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.292400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.301750E-01 |
| Normal-vs-Grade 2 |
1.561820E-04 |
| Normal-vs-Grade 3 |
9.46100000009942E-07 |
| Normal-vs-Grade 4 |
1.62859999996989E-06 |
| Grade 1-vs-Grade 2 |
5.239600E-03 |
| Grade 1-vs-Grade 3 |
2.879800E-03 |
| Grade 1-vs-Grade 4 |
7.563400E-04 |
| Grade 2-vs-Grade 3 |
1.358050E-01 |
| Grade 2-vs-Grade 4 |
1.870120E-02 |
| Grade 3-vs-Grade 4 |
2.598800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.082310E-02 |
| Normal-vs-ccB subtype |
1.86779999999942E-06 |
| ccA subtype-vs-ccB subtype |
9.944300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.06209999999274E-05 |
| Normal-vs-N1 |
6.867900E-02 |
| N0-vs-N1 |
4.615600E-01 |
|
|
